Featured Article
FDA Approves New Sublingual Films to Treat Opioid Dependence
FDA Approves New Sublingual Films to Treat Opioid Dependence

The FDA has approved a new 16 mg/4 mg buprenorphine-naloxone sublingual film to treat opioid dependence. Called Cassipa, it is made by Teva Pharmaceuticals USA Inc. In June, the FDA also approved the first generic versions of buprenorphine-naloxone sublingual film for opioid ...

Read More

Blog posts in October

  • Opioid treatment outcomes are worse for women: Study

    Women are not getting the kind of opioid addiction treatment they should be getting. That’s not because women aren’t loved or appreciated. It’s ...

    View More
  • Senate Passes Sweeping Bipartisan Opioid Bill

    In a strongly bipartisan 98-1 vote, the Senate has approved massive new legislation aimed at combating the opioid epidemic, and sent it on to the ...

    View More
  • Most older adults aren't counseled on leftover opioids

    Do you ever just take some of an opioid prescription, and then hang on to what’s left over in case you want it sometime in the future? This is not ...

    View More
  • Alcohol Causes Over Five Percent of Deaths Worldwide

    A study from the UN's World Health Organization (WHO) has revealed that more than 3 million people died in 2016 as a result of the harmful use of ...

    View More

Start Your New Path to Sobriety Today!

    • Please enter your name.
    • This isn't a valid phone number.
    • Please enter your email address.
      This isn't a valid email address.
    • Please make a selection.
    • Please enter a message.